期刊文献+

重组人白介素-10对大鼠肺缺血再灌注损伤的保护作用 被引量:1

Protective effects of recombinant human interleukin 10 on lung ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的:探讨重组人白介素-10(rhIL-10)对大鼠肺缺血再灌注损伤的保护作用及可能机制。方法:显微镜下夹闭左肺动静脉和左主支气管建立单肺缺血再灌注模型。72只Wistar大鼠随机分为对照组(Control组)、缺血再灌注组(IR组)、rhIL-10药物干预组(rhIL-10组),每组分为缺血45min、再灌注60、120min 3个时间点。每个时间点8只,共24只。按上述时间点处死收集标本,检测血浆TNF-α、丙二醛(MDA)水平,观察肺组织病理变化。结果:各组MDA在缺血45min时差异无统计学意义(P>0.05),再灌注60min和120min时IR组明显升高,而rhIL-10组虽较Control组升高,但明显低于IR组(P<0.05)。与Control组比较,IR组缺血45min时TNF-α水平明显升高(P<0.05),rhIL-10组无明显变化(P>0.05)。再灌注60min和120min时IR组TNF-α水平较Control组明显升高(P<0.05),而rhIL-10组虽较Control组显著升高(P<0.05),但明显低于IR组(P<0.05)。肺病理提示肺泡间隔及肺泡内炎性细胞浸润,肺泡腔内大量炎性细胞渗出、出血,且随着再灌注时间的延长,损伤加重。rhIL-10组病理损伤均较IR组为轻。结论:rhIL-10可能通过抑制氧自由基生成、中性粒细胞浸润、TNF-α反应对肺缺血再灌注损伤起保护作用。 AIM:To evaluate the protective effects of recombinant human interleukin 10 on lung ischemia-reperfusion injury in rats and its possible mechanisms.METHODS: Rat models of lung ischemia-reperfusion were established by clamping of the left pulmonary arteries,left pulmonary veins and left main bronchus.72 healthy Wistar rats were randomly divided into three groups: surgical control group(group Control),ischemia-reperfusion group(group IR) and recombinant human interleukin 10 pretreated group(group rhIL-10).Every group included 24 rats(8 rats at 45 min ischemia,60 min and 120 min reperfusion respectively).Rats were sacrificed at relative time point collecting the plasma and lung sample.The plasma contents of malondialdehyde(MDA) and TNF-α were determined.Lung pathology were examined.RESULTS:The plasma content of MDA was not different statistically among three groups after 45 min of ischemia(P0.05).Both group IR and group rhIL-10 showed significantly increased MDA content relative to group Control,while group rhIL-10 was lower than that of group IR after 60 min of reperfusion and 120 min of reperfusion(P0.05).The plasma content of TNF-α in group IR was increasing significantly relative to group Control after 45 min of ischemia(P0.05).The content of TNF-α in group rhIL-10 was not different statistically compared with group Control(P0.05).Both group IR and group rhIL-10 showed significantly increased TNF-α content relative to group Control while group rhIL-10 was lower than that of group IR after 60 min of reperfusion and 120 min of reperfusion(P0.05).Pathological examination showed severe polymorphonuclear leukocytes infiltration with bleeding.Group IR was worse than group rhIL-10 on the pathological examination.CONCLUSION: Pretreatment with rhIL-10 protected the lungs against ischemia-reperfusion injury possibly by suppressing PMN infiltration,reducing production of oxygen radicals,inhibiting reacting of TNF-α.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第11期1239-1243,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 重组人白介素-10 肺缺血再灌注损伤 氧自由基 rhIL-10 Lung ischemia-reperfusion injury Oxygen radicals
  • 相关文献

参考文献11

  • 1Carvalho EM, Gabriel EA, Salerno TA. Pulmonary protection during cardiac surgery: systematic literature review[J]. Asian Cardiovasc Thorac Ann, 2008,16(6) : 503-- 507.
  • 2Akdis CA, Blaser K. Mechanisms of interleukin-10- mediated immune suppression [J]. Immunology, 2001,103(2) : 131-- 136.
  • 3Okada M, Yamashita C, Okada K. Contribution of endothelin-1 to warm ischemia/reperfusion injury of the rat lung[J]. Am J Respir Crit Care Med,1995, 152(6) : 2105--2110.
  • 4Den Hengst WA, Gielis JF, Lin JY. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process[J]. Am J Physiol Heart Circ Physiol, 2010,299 (5) :H1283 --H1299.
  • 5金丽威 ,郑捷 .白介素10家族研究近况[J].国外医学(免疫学分册),2005,28(4):246-249. 被引量:13
  • 6吴艳霞,付雷,黄浩.大黄素对心肌梗死后小鼠心肌组织TNF-α、IL-10基因表达和NF-κB活性的影响[J].中国临床药理学与治疗学,2010,15(3):287-291. 被引量:5
  • 7Khimenko PL, Bagby GJ, Fuseler J, et al. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs[J].J Appl Physiol,1998,85:2005- 2011.
  • 8Zhao M, Fernandez LG, Doctor A, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury [J].Am J Physiol Lung Cell Mol Physiol, 2006, 291 (5): L1018--L1026.
  • 9Tomasdottir H, Hjartartarson H, Ricksten A, et al. Tumor necrosis factor gene polymorphism is associ ated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery[J]. Anesth Analg, 2003,97 ( 4 ) : 944 -- 949.
  • 10Esme H, Fidan H, Koken T, et al. Effect of lung ischemia-reperfusion on oxidative stress parameters of remote tissues [J]. Eur J Cardiothorac Surg, 2006,29(3): 294--298.

二级参考文献31

  • 1卢延旭,陈敏珠.可溶性鸡Ⅱ型胶原对大鼠胶原性关节炎的免疫治疗作用[J].中国药理学与毒理学杂志,2004,18(5):365-370. 被引量:2
  • 2匡彦德.白细胞介素2的检测及其诱生条件的分析[J].上海医科大学学报,1987,14(1):10-10.
  • 3[6]Gitter BD, Labus JM, Lees SL, Scheetz ME. Characteristics of human synovial fibroblast activation by IL-1 and TNFβ[J]. Immunology, 1989;66(2): 196 - 200
  • 4[8]Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen induced arthritis[J]. Eur J Immunol, 1996;26(7): 1511 - 8
  • 5[9]Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs M J,Goldman M. et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis[J]. Arthritis Rheum, 1997;40(2) :249 - 60
  • 6[10]Wilckens T, Rijk RD. Glucocorticoids and immune function:unknown dimensions and new fronters [ J ]. Immunol Today,1997; 18(9) :418 - 23
  • 7Kotenko SV.The family of IL-10-related cytokines and their receptors:related,but to what extent[J]. Cytokine Growth Factor Rev,2002, 13(3):223-240.
  • 8Conti P, Kempumj D. lit 10 subfamily members: IL-19, IL-20,IL-22,IL-24 and IL-26[J]. Immunol Lett, 2003,88(3): 171-174.
  • 9Fickenscher H, Her S, Kupers H, et al. The interleukin-10 family of cytokines[J]. Trends Immuno1,2002,23(3): 89-96.
  • 10Gallagher G, Dickensheets H. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10(IL-10) [J]. Genes Immunol, 2000,1(7):442-450.

共引文献16

同被引文献14

  • 1陶冬英,陈平圣,刘东风.季德胜蛇药片对大鼠急性肺损伤的保护作用[J].中华急诊医学杂志,2006,15(3):223-227. 被引量:3
  • 2罗海燕,孙宗全,蒋雄刚,冯汉萍,孙图成,陈新忠,冯剑锷,江萍.基质金属蛋白酶抑制剂对肺缺血再灌注损伤的保护作用[J].华中科技大学学报(医学版),2007,36(2):206-209. 被引量:6
  • 3Yano M, Omoto Y, Yamakawa Y, et al. Increased matrix metalloproteinase 9 activity and mRNA ex pression in lung ischemia reperfusion injury [J]. Heart Lung Transplant, 2001, 20(6): 679-686.
  • 4Yeh DY, Lin HI, Feng NH, et al. Matrix metallo protease expressions in both reperfusion lung injury and oleie acid lung injury models and the protective effects of ilomastat[J]. Transplant Proc, 2009, 41 (5) : 1508-1511.
  • 5Shimoyama T, Tabuchi N, Chung J, et al. Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung [J]. Med Sci Monit, 2006, 12(2): BR51- BR56.
  • 6Sommer SP, Sommer S, Sinha B, et ah Ischemia reperfusion injury-induced pulmonary mitochondrial damage [J]. Heart Lung Transplant, 2011, 30(7): 811-818.
  • 7Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinases as drug targets in ische- mia/ reperfusion injury[J]. Drug Discov Today, 2011, 16(17/18): 762-778.
  • 8王莉.基质金属蛋白酶抑制剂的筛选的研究[D].南京:东南大学基础医学院.
  • 9Eppinger MJ, Deeb GM, Boiling SF, et al. Media- tors of ischemia-reperfusion injury of rat lung[J]. Am J Pathol, 1997, 150(5): 1773-1784.
  • 10陶冬英.季德胜蛇药片对大鼠ALI/ARDS的预防作用研究[D].南京:东南大学基础医学院.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部